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chieving Quality in Cardiovascular Imaging II
roceedings From the Second American College of Cardiology–Duke
niversity Medical Center Think Tank on Quality in Cardiovascular Imaging
amela S. Douglas, MD, MACC, FASE, FAHA,* Jersey Chen, MD,†
inda Gillam, MD, FACC,‡ Robert Hendel, MD, FACC,§
. Gregory Hundley, MD, FACC, Frederick Masoudi, MD, FACC,¶
anesh R. Patel, MD,* Eric Peterson, MD, FACC, FAHA*
urham, North Carolina; New Haven, Connecticut; New York, New York; Winfield, Illinois;
inston-Salem, North Carolina; and Denver, Colorado
espite rapid technologic advances and sustained growth, less attention has been focused on quality in
maging than in other areas of cardiovascular medicine. To address this deﬁcit, representatives from
ardiovascular imaging societies, private payers, government agencies, the medical imaging industry, and
xperts in quality measurement met in the second Quality in Cardiovascular Imaging Think Tank. The
articipants endorsed the previous consensus deﬁnition of quality in imaging and proposed quality
easures. Additional areas of needed effort included data standardization and structured reporting,
ppropriateness criteria, imaging registries, laboratory accreditation, partnership development, and imaging
esearch. The second American College of Cardiology–Duke University Think Tank continued the process of
he development, dissemination, and adoption of quality improvement initiatives for all cardiovascularmaging modalities.
a
d
w
c
d
q
i
d
g
A
c
S
d
r
s
z
i
S
C
Sechnological innovations such as novel
contrast agents, molecular radionuclide
imaging, computed tomography (CT)
angiography of the coronary arteries, and
ardiac magnetic resonance (CMR) are trans-
orming cardiovascular imaging and providing
nhanced capabilities for diagnosing adverse
edical conditions and implementing effective
herapy. However, increasing growth in the use
rom the *Division of Cardiovascular Medicine, Duke University
edical Center, Durham, North Carolina; †Department of Car-
iovascular Medicine, Yale School of Medicine, New Haven,
onnecticut; ‡Department of Cardiology, Columbia University,
ew York, New York; §MidWest Heart Specialists, Winfield,
llinois; Department of Cardiology, Wake Forest University Bap-
ist Medical Center, Winston-Salem, North Carolina; ¶Division of
ardiology, Denver Health Medical Center, Denver, Colorado. In
ollaboration with the American College of Cardiology Cardiovascular
maging Collaborative Quality Task Force, American College of
adiology, American Heart Association, American Society of Echo-ardiography, American Society of Nuclear Cardiology, Certification
oard of Nuclear Cardiology, Heart Rhythm Society, Intersocietal
M
2nd cost of cardiovascular imaging procedures
uring the past decade has raised concerns
ithin the U.S. government and other health
are payers (1), whereas the evidence base for
emonstrating how imaging in general, and
uality of imaging in particular, contributes to
mproved patient outcomes for cardiovascular
iseases has admittedly lagged behind this
rowth. Proposals to improve quality standards
ccreditation Commission, North American Society for Cardiovas-
ular Imaging, Society of Atherosclerosis Imaging and Prevention,
ociety of Cardiovascular Computed Tomography, Society for Car-
iovascular Magnetic Resonance, Society for Cardiovascular Angiog-
aphy and Intervention, and the Society for Vascular Medicine. Please
ee the Online Appendix for complete list of participants and organi-
ations. The following companies provided sponsorship for the meet-
ng: Aetna, Astellas Pharma US, Inc., AstraZeneca, Bristol-Myers
quibb Medical Imaging, Covidien, GE Healthcare, The Medicines
ompany, MEDRAD, Inc., Philips Ultrasound, Siemens Medical
olutions, and United Healthcare.anuscript received November 6, 2008; accepted November 21,
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232n cardiovascular imaging, similar to
hose developed in other aspects of
ealthcare, have been suggested to fa-
ilitate the appropriate delivery of these
ew technologies and ensure that they
mprove patient outcomes and public
ealth.
In January 2006, the American Col-
ege of Cardiology (ACC) and Duke
niversity convened a meeting of rep-
esentatives of cardiovascular imaging
ocieties, private payers, government
gencies, industry, and experts in out-
omes assessment to define quality in
maging and identify a preliminary list
f opportunities for improving quality
i.e., Imaging Quality Think Tank I)
Fig. 1) (2). Major domains for quality
ssessment and improvement were lab-
ratory structure, patient selection, im-
ge acquisition, image interpretation,
esults communication, and patient
utcomes. A convergence of opinion
as reached on multiple metrics of
uality for each domain and across
maging modalities, enabling subse-
uent work by individual societies and
onsortia to develop explicit quality
easures.
A second meeting (Imaging Quality
hink Tank II) with similarly broad
epresentation was held in October
007 to build on the first conference,
eport on the progress of the interven-
ng 18 months, and focus on tools and
rocesses that would further quality
easurement and improvement. The
eliberations and conclusions of this
eeting form the substance of this
eport. Subsequent meetings are envi-
ioned to advance the field by address-
ng the implementation of these tools,
rocesses, and standards in quality im-
rovement strategies.
rogress Since Imaging Quality
hink Tank I
uch has been accomplished since the
evelopment of a cross-modality action
lan modeled on domains of imaging
are at the conclusion of Think Tank I.
espite payers’ pressures to reduce the aosts of imaging, there has been sus-
ained cooperation among all imaging
rovider groups in their commitment
o advance the quality agenda across all
odalities; at the same time, innovative
odality-specific projects also have
merged. A summary of the activities
n each domain of quality in imaging is
resented in Table 1.
Currently, quality in laboratory
tructure is assessed primarily by ac-
reditation. Laboratory accreditation
an be obtained for CT, MR, nuclear,
nd ultrasound laboratories through
ither the American College of Radi-
logy (ACR) or the Intersocietal Ac-
reditation Commission (IAC). Under
he umbrella of the IAC, laboratory
ccreditation is available for noninvasive
ascular imaging (ICAVL), echocardi-
graphy (ICAEL), nuclear cardiolo-
y (ICANL), computed tomography
ICACTL), and magnetic resonance
maging (ICAMRL). A complete list
f sponsoring organizations is available
t the IAC website (3). Accreditation
tandards of both organizations em-
hasize physician and technologist
raining, equipment performance,
maging protocols, report content,
nd timeliness. In addition, accredi-
ation bodies mandate periodic sub-
ission of sample studies to monitor
he quality of imaging acquisition.
ngoing quality improvement initia-
ives and continuing medical educa-
ion also are required.
Although accreditation is a voluntary
rocess, in the past 2 years an increas-
ng number of payers have mandated
Image
Acquisition
Patient
Laboratory
Patient 
Selection
Figure 1. Dimensions of Care Framework for Eva
Reproduced from Douglas et al. (2) with permissionccreditation for reimbursement, a con- wept endorsed by several medical soci-
ties, including ACC, ACR, the
merican Society of Echocardiography
ASE), and the American Society of
uclear Cardiology. Societies have cre-
ted resources for laboratories seeking
ccreditation—ASE’s Echo ToolBox
4) is an example of a quality assurance
rogram that facilitates accreditation, a
ey element of which is an online
tructured reporting system. Similarly,
he ACR also has developed modules
or CT, CMR, ultrasound, and nuclear
edicine/positron emission tomogra-
hy (5–7).
Significant progress also has been
ade in optimizing patient selection
hrough the development of appropri-
teness criteria by the ACC Founda-
ion, often in conjunction with imaging
ocieties, the American Heart Associa-
ion (AHA), and ACR. The ACC
oundation Appropriate Use Criteria
or nuclear cardiology (8), cardiac CT
nd MRI (9), resting transthoracic and
ransesophageal echocardiography (10),
nd stress echocardiography (11) have
een published. The ACR also has
ross-modality appropriateness criteria
or cardiac-based clinical variants (12).
rojects to implement and evaluate the
pplication of imaging appropriateness
riteria in practice are underway. The
uclear cardiology criteria are being
pdated and a document focusing on
ross-modality noninvasive imaging
riteria is in progress. Finally, the ap-
ropriateness of coronary revasculariza-
ion, often a goal of diagnostic imaging,
Image
terpretation
Results
Communication
ructure
Improved
Patient 
Care
(Outcomes)
ting Quality of Cardiovascular ImagingIn
 St
luaill be published in 2008. Additional
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233ollaborations between organizations
re being investigated.
Improving quality of image acquisi-
ion and results communication has
een addressed through the develop-
ent of modality-specific imaging pro-
ocols. For example, the Society for
ardiovascular Magnetic Resonance
as published specific imaging proto-
ols for each major diagnosis category
13). The American Society of Nuclear
ardiology also has published revised
uidelines for image acquisition, pro-
essing, display, and reporting (14).
ssues of patient safety often reside in
he domain of image acquisition (e.g.,
ephrogenic systemic fibrosis/contrast
llergy, CMR safety, diagnostic refer-
nce levels in X-ray imaging, echo con-
rast agents) and have been addressed
n modality specific fashion. For exam-
le, the ACR has developed specific
ools that provide guidance for the safe
dministration of contrast (15), CMR
Table 1. Steps in Quality of Cardiovascular Imag
ACC
Laboratory structure
Accreditation C
Tools for achieving lab accreditation —
Technologist credentialing —
MD credentialing C
Patient selection
Appropriateness criteria (AC) C
Tools for evaluating AC C
Tools for implementing AC IP
Image acquisition
Imaging protocols —
Image interpretation
Standards for variability —
Standardized image set —
Results communication
Key data elements C
Structured reporting C
Timeliness guidelines —
Improved outcomes
Metrics for measuring outcomes —
Patient satisfaction —
Assessments of status were provided by each society, and n
C  complete; ACC  American College of Cardiology; ACR
IP  in process/planned; NASCI  North American Society
Computed Tomography; SCMR  Society for Cardiovascularafety (16), as well as providing relative tadiation levels in their appropriateness
riteria when applicable.
Tools for improving and measuring
uality in image interpretation include
nline reference image libraries and
tatements concerning interobserver
nd intraobserver variability. Criteria
or training in the newer imaging mo-
alities of CT and MRI have been
eveloped. Proficiency examinations
re well accepted in echocardiography
nd nuclear cardiology; a board exam
or CT has been created, a CMR exam
s imminent (17,18), and the American
oard of Radiology, since 2004, has
ad a dedicated cardiac section of their
ral board examination. Recognizing
he challenge of meeting multimodality
raining requirements within the con-
traints of a traditional cardiology fel-
owship, the ACC has recently updated
ts adult cardiology fellowship training
ecommendations with improved train-
ng in newer modalities through a mul-
by Subspecialty/Society
ACR ASE ASNC NASCI
C C C IP
— C — —
C C C —
C C C IP
C C C C
IP IP C IP
IP IP IP —
C C C IP
C — IP —
C C IP IP
IP C C IP
IP IP IP IP
IP C C IP
IP — — —
IP — — —
therwise veriﬁed.
merican College of Radiology; ASNC  American Society of Nu
ardiovascular Imaging; SCAI  Society for Cardiovascular An
netic Resonance; and SVM  Society for Vascular Medicine.imodality approach (19). cAt the same time that modality
pecific reporting guidelines are being
onsidered, it has been recognized
hat a major need exists for cross-
odality reporting data standards.
n ACC-supported, multisociety
uality in Imaging Working Group
volved from Think Tank I and data
tandards for imaging are in press
20). In addition, potential metrics
or quality in results communication
n the form of guidelines for timeli-
ess of reporting have also been de-
eloped (21).
The final stage of the quality in
maging continuum is patient outcome.
emonstrating improved outcomes at-
ributable to cardiovascular imaging is
articularly challenging because of the
omplex interplay of patient character-
stics and treatment strategies, includ-
ng the substantial variability in thera-
eutic care patterns after cardiac
maging. Nevertheless, the scientific
SCCT SCMR SVM SCAI
C C C C
— — — —
— C C C
IP C C C
C C IP C
— — — —
— — — —
IP C C —
— — — —
— IP C —
IP IP — —
— IP — —
C IP — IP
— — — IP
— — — IP
r Cardiology; ASE  American Society of Echocardiography;
raphy and Interventions; SCCT  Society of Cardiovascularing
ot o
 A clea
for C giogommunity rose to the challenge of
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234valuating cardiac imaging and patient
utcomes through a National Heart
ung Blood Institute-sponsored work-
hop on “Outcomes Research in Car-
iovascular Imaging,” held in the sum-
er of 2008.
Since Think Tank I, there have
een other initiatives that potentially
nvolve all elements of the quality in
maging continuum. They include the
reation of data registries such as the
ociety of Cardiovascular Computed
omography/Blue Cross Blue Shield
ollaboration on coronary CT an-
iography; educational activities by
ultiple participants, including the
CR Education Center; the develop-
ent of radiation safety resources
Society for Cardiovascular Angiog-
aphy and Interventions, ACR); pro-
ision of grant support for research in
uality (ACR, ASE), and a planned
equest for recognition of Vascular
edicine as an American Board of
edical Specialists subspecialty (So-
iety for Vascular Medicine). The list
resented here is not intended to be
Table 2. Recommendations From Imaging Qualit
A. Data Standardization and Structured Reporting
1. Complete and adopt standardized multimodal
2. Develop a multi stakeholder policy statement
3. Create Internet- and computer-based structure
4. Consider requiring structured reporting incorp
B. Appropriateness Criteria
1. Complete ongoing appropriateness criteria, re
2. Continue research evaluating existing and futu
3. Collaborate with providers and payers to impl
4. Develop standardized data elements to evalua
C. Imaging Registries
1. Create a multicenter imaging registry(s).
2. Explore development of a national imaging re
3. Investigate incentives to maximize participatio
D. Accreditation
1. Continue to improve accreditation processes a
2. Investigate the feasibility of incorporating add
3. Initiate studies evaluating the effect of laborat
E. Partnership Development
1. Continue communication and collaboration be
F. Research
1. Deﬁne meaningful outcome measures for clini
2. Promote the implementation of data standard
3. Continue multistakeholder investment in imag
sites capable of performing multimodality ima
4. Develop new and existing funding sources.xhaustive but rather to recognize the preadth of new and ongoing imaging
uality activities.
indings From Imaging Quality
hink Tank II
uilding on the “dimensions of care
ramework” from Think Tank I, Imag-
ng Quality Think Tank II turned its
ttention to cross-modality issues that
ranscend the domain paradigm. This
ection describes the challenges in and
otential solutions for developing sys-
ems to evaluate and improve quality in
ardiovascular imaging (Table 2).
ata standardization and structured
eporting. Communication of the re-
ults of a cardiovascular imaging study
s perhaps the most critical step of an
maging procedure. An ideal report is
lear, uses consistent terminology and
rovides referring physicians with data
hat are complete and clinically rele-
ant. In the past, societies have at-
empted to provide guidance for re-
orting (22,23), and educational efforts
ave focused on creating a common
hink Tank II
ata deﬁnitions and elements.
cating structured reporting implementation using e
porting tools accessible to all laboratories and imag
ing standardized data elements for imaging laborato
existing single-modality documents and develop mu
ppropriateness criteria.
nt appropriateness criteria.
ppropriateness of indications for cardiovascular imag
y that allows for multimodality and multispecialty pa
cardiovascular imaging registry(s).
tandards.
al quality metrics, such as structured reporting.
accreditation on patient outcomes.
en stakeholders to develop and implement imaging
rials evaluating cardiovascular imaging.
facilitate large-scale, high-impact imaging research.
research, including creating an infrastructure for a na
.arlance. However, substantial varia- tion remains, leading to confusion
hen one reviews imaging reports and
otential errors when one incorporates
he data from imaging into clinical
ecision-making. The Think Tank II
articipants reached an overwhelming
onsensus in support of the importance
f structured reporting in imaging by
sing common data elements as a solu-
ion that would improve both clinical
are and research.
Several organizations have developed
dictionary or lexicon of key terms, but
hese have been done in relative isola-
ion (24,25). Since Think Tank I, an
CC/AHA Writing Group for Data
tandards in Cardiac Imaging, over-
een by the ACC/AHA Task Force on
ata Standards and comprising repre-
entatives from all cardiovascular imag-
ng societies, has written a document
efining key terminology essential for
ardiac imaging procedures, including
ngiography, cardiovascular CT/CMR,
chocardiography, and nuclear cardiol-
gy (20). This statement provides uni-
orm language across imaging modali-
g consensus data standards.
roviders compliant with data standards.
ccreditation and reimbursement.
odality appropriateness document.
pation.
ity tools and processes.
al imaging registry and developing a network ofy T
ity d
advo xistin
d re ing p
orat ry a
ﬁne ltim
re a
eme
te a ing.
gistr rtici
n in
nd s
ition
ory
twe qual
cal t
s to
ing tion
gingies and delineates key data fields used
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235or reporting and that might be incor-
orated into databases/registries. Ef-
orts were made to use established
erms and definitions from groups such
s the Radiological Society of North
merica with RadLEx (25) and the
HA/ACC Data Standards Commit-
ee, who have previously developed
ommon definitions for heart failure
26), atrial fibrillation (27), and cardiac
atheterization data (28).
After creating common data ele-
ents, structured reporting can be im-
lemented. In contrast to free text re-
orting, the combination of data
tandardization and structured report-
ng would promote consistency of re-
ort language and complete data pre-
entation. The vision of a uniform
utput from structured reporting in-
ludes the ability to compare clinical
ata from multiple modalities and
ealth care providers. Automatic re-
orting systems also could encourage
apid dissemination of study results via
utofaxing or electronic communica-
ion. Quality assessment and improve-
ent activities can include analysis of
atterns of utilization, appropriateness,
nd outcomes, potentially through in-
orporation into electronic health
ecords or an imaging registry. As proof
f concept, Italian investigators have
reated a large regional database of
chocardiographic data for quality im-
rovement and epidemiologic studies
29,30).
The ACC in conjunction with repre-
entatives from all cardiovascular imaging
ocieties, AHA and ACR, also has re-
ently published a policy statement advo-
ating the use of structured reporting and
ata formatting/archiving in imaging
31). This statement recommends work-
ng closely with umbrella groups such
s Digital Imaging and Communications
n Medicine (DICOM) and Integrating
he Healthcare Enterprise. For example,
he expertise and previous work of the
ICOM Standards Committee of the
edical Imaging and Technology Alli-
nce, and their Workgroup 01 on Car-
iac and Vascular Information could beeveraged to address some of the opera-
ional barriers to structured reporting.
ndustry will play a critical role in creat-
ng tools; standards should allow for cre-
tivity and differentiation of individual
endors’ products but should require suf-
cient uniformity to facilitate integration
cross the spectrum of end-users. A
ollow-up activity of this meeting is to
egin a dialog in earnest with Integrating
he Healthcare Enterprise and DICOM,
long with key industry groups such as
he Medical Imaging Technology Alli-
nce, to determinate how best to move
owards a universally accepted structured
eporting standard.
The development of report templates
ill also help to drive the structured
eporting initiative and to that end the
CR and NASCI have developed a
aper entitled: “Structured reporting:
oronary CT Angiography—A White
aper from the ACR and NASCI” that
ncludes such templates (30).
Although Think Tank II participants
ere strongly supportive of efforts to
efine and promote data standards and
tructured reporting, this effort can only
e successful with backing of all imaging
takeholders, institution of accreditation
nd regulatory requirements, broad avail-
bility of compliant computerized report-
ng systems, as well as substantial pro-
ider education. Think Tank II members
ctive in each of these areas were com-
itted to moving forward to provide the
ools, knowledge base, and business case
or implementation.
The participants of Imaging Quality
hink Tank II made the following
ecommendations:
1. Complete and adopt standardized
multimodality data definitions
and elements.
2. Develop a multistakeholder pol-
icy statement advocating struc-
tured reporting implementation
using existing consensus data
standards.
3. Create Internet- and computer-
based structured reporting tools othat are compliant with data stan-
dards and accessible to all labora-
tories and imaging providers.
4. Consider requiring structured re-
porting incorporating standard-
ized data elements for imaging
laboratory accreditation and re-
imbursement.
ppropriateness criteria. Appropriate-
ess criteria for imaging were identified
n Think Tank I as an important initial
tep towards reducing unwarranted
esting and variation in cardiovascular
maging. By the time Think Tank II
as convened, appropriateness criteria
or single-photon emission computed
omography (8), transthoracic and
ransesophageal echocardiography (10),
nd cardiac CT/CMR (9) were pub-
ished or in press. These criteria were
he culmination of 2 years of intense
ultispecialty, multisociety work aimed
t producing guidance for practicing cli-
icians. As such, the development and
mplementation of the criteria were be-
ieved to represent noteworthy solutions
or improving patient selection for imag-
ng studies, including a future structure
or evaluating national patterns of care
nce data standards and structured re-
orting were established. Additional
ork is required to complete a full set of
ppropriateness criteria documents, to re-
ise existing documents, and to create the
rst multimodality appropriateness crite-
ia for ACC. As with other documents,
CC and ACR will work collaboratively
n development of these multimodality
ppropriateness criteria.
Think Tank II participants also rec-
gnized the importance of developing
ools to evaluate appropriateness crite-
ia and assist providers and payers in
heir implementation. Key areas of
eed include appropriateness assess-
ent tools implemented either at
oint-of-service (imaging laboratory)
r point-of-order (referring clinician)
or one or multiple modalities; trans-
arency in the classification of indica-
ions for imaging studies; mechanisms
o enhance communication between
rdering provider and image inter-
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236reter; and data-driven solutions such
s universal patient indexing and auto-
ated strategies to collect indications
nd outcomes. Many of the stakehold-
rs recommended developing these
ypes of solutions as potential, quality
nhancing alternatives to the use of
adiology benefit managers.
Pilot studies evaluating appropriate-
ess tools across geographic regions and
ractice types would also add valuable
xperience. Together, ACC and United
ealthcare are conducting a pilot pro-
ram to evaluate the implementation of
ppropriateness criteria for myocardial
erfusion imaging using an internet-
ased tool (32), whereas several investi-
ators have reviewed the applicability of
he criteria to patients in their laborato-
ies (33). Additional programs are
eeded to develop strategies to reduce
nnecessary testing and duplication.
The participants of Imaging Quality
hink Tank II made the following
ecommendations:
1. Complete on-going appropri-
ateness criteria, refine existing
single-modality documents and
develop multi-modality appro-
priateness document.
2. Continue research evaluating ap-
propriateness criteria.
3. Collaborate with providers and
payers to implement appropriate-
ness criteria.
4. Develop standardized data ele-
ments to evaluate appropriate-
ness of indications for cardiovas-
cular imaging.
maging registries. Multicenter regis-
ries have proved instrumental for eval-
ating and improving quality of care for
cute coronary syndromes (34–36) and
ardiovascular procedures such as car-
iac surgery and cardiac catheterization
37,38). An analogous approach using
egistries for cardiovascular imaging
olds great promise for improving
afety and quality. Such registries
ould allow us to better understand the
atterns of use in community practice
s well as evaluating diagnostic and orognostic value. Although exciting,
he feasibility of establishing large im-
ging registries is challenging on sev-
ral fronts: technical (few data stan-
ards or integrated electronic data
ollection tools), operational (limited
linician time for data collection and
bstacles to longitudinal evaluation),
nd financial (providing the business
ase for payer, provider, and manufac-
urer engagement).
An ideal imaging registry would ac-
urately capture information on who
rdered a study, the indications for
maging, patient demographic and clin-
cal information, image acquisition pa-
ameters, study findings, and workflow
etrics. A registry’s value would be
urther enhanced if these data were
inkable, within and among data
ources, to create a longitudinal record
f a patient’s subsequent care and out-
omes. Once created, an ideal registry
hould provide feedback to clinicians
hrough benchmarked data on their
are to stimulate quality improvement.
he Agency for Healthcare Research
nd Quality has recently summarized
urther important functionalities for
deal registries (39).
Unfortunately, currently there are
ew registries for noninvasive imaging.
hose that do exist fall into 1 of 3
ategories: “institutional case series”
hat are small in size, often nonrepre-
entative or of limited generalizability,
nd lacking downstream outcomes in-
ormation; registries based on adminis-
rative data from large health insurers;
r those from integrated healthcare
roviders (e.g., Veterans Administra-
ion hospitals or health maintenance
rganizations). Although administra-
ive databases are good sources for
tudying patterns of cardiovascular im-
ging utilization, they commonly lack
he clinical detail necessary to address
hy tests were ordered or the accuracy
f interpretation. However, ACR and
CC are working collaboratively to
stablish a registry for cardiac com-
uted tomography angiography based
n existing models from ACR in non- Aardiac areas of imaging and from the
CC National Cardiovascular Data
egistry’s (NCDR) registries.
In contemplating a future imaging
egistry, it is necessary to define the
usiness case to support cardiovascular
maging registries. One mechanism
ould be linking registry participation
ith reimbursement. In 2006, the
enters for Medicare and Medicaid
ervices (CMS) released a guidance
ocument (40) that describes the cir-
umstances under which CMS would
ssue a national coverage determination
hat requires collection of additional
atient data to supplement standard
laims data. Since then, CMS has used
his mechanism to prompt the develop-
ent of several national registries, in-
luding the ACC-NCDR implantable
ardiac defibrillator registry (41).
Large private insurers could be an
lternative force to motivate a broad-
ased imaging registry as rising costs in
ardiovascular imaging are a major con-
ern. Yet, their current means of con-
rolling this growth, such as time-
onsuming pre-approval processes,
ave been generally ineffective over the
ong term and are viewed as intrusive by
oth patients and their physicians. As
n alternative, payers could provide in-
entives to caregivers for participation
n a multimodality clinical data registry
ncluding waiver of the pre-approval pro-
ess, preferred provider status (based on
articipation), pay for participation, or
ay for (appropriate) imaging perfor-
ance.
A third potential supporter of imag-
ng registries could be the manufactur-
rs of imaging equipment or materials
contrast agents, isotopes, and so on).
large high-quality imaging registry
ould facilitate the evidence develop-
ent process both before and after
pproval. To date, however, neither the
ood and Drug Administration nor
linicians in practice have required such
vidence, so industry engagement has
een somewhat limited.
A fourth potential supporter is themerican College of Radiology Imag-
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237ng Network (42), which has raised
unds to launch a cardiovascular imag-
ng research effort. Recently estab-
ished, its cardiovascular research prior-
ties are still in development. Future
tudy designs could include registries,
andomized clinical trials or other
fforts.
Once the resources and incentives
or an imaging registry are manifest,
he challenge will be to reduce barriers
o provider participation. Data regard-
ng the patient’s clinical characteristics
s well as the reasons for the test should
deally be collected from the physician
rdering the study. The evolution of
lectronic healthcare record systems
ith computer order entry at many
enters may streamline such data col-
ection in the future using standardized
omenclature and formats as noted
reviously. These combined data then
ould be aggregated into a multivendor,
ulticenter clinical data warehouse
uch as currently is done by the regis-
ries managed by ACC-NCDR and
CR-NRDR. Finally, appropriate an-
lytic methodology should be applied
o these data to allow for meaningful
esearch and provider feedback systems.
The participants of Imaging Quality
hink Tank II made the following
ecommendations:
1. Create a multicenter imaging
registry(s).
2. Explore development of a na-
tional imaging registry that allows
for multimodality and multispe-
cialty participation.
3. Investigate incentives to maxi-
mize participation in cardiovas-
cular imaging registry(s).
ccreditation. Accreditation of imaging
aboratories ensures the presence of ba-
ic structural elements of a quality im-
ging study process and is increasingly
eing tied to reimbursement. Think
ank II participants believed that the
ccreditation process represents an
mportant resource for both quality
mprovement and research, and as alatform for measuring quality in car-
iovascular imaging.
It was felt that several features of
he current accreditation process
ould be improved and warrant study.
irst, the process is based on a one-
ime submission of applicant-selected
ases and documents. Although the
ptions of site visits and random
ost-accreditation audits exist, these
re rarely performed. Review of un-
elected studies from laboratories
ould better establish “real-world”
uality and remove the opportunity for
ias by “cherry picking” only the best
tudies for review. However, this will
eed to be approached carefully since
here are other factors that are consid-
red as part of the image quality eval-
ation. All applicant images must be
easured against the same standard.
ther factors can affect the images
vailable for submission on any given
ay such as low patient volume, patient
ody habitus, comorbidities, and pa-
ient cooperation. Moreover, although
he requirements for accreditation have
een carefully selected with the input of
ubspecialty societies and experts in the
odality, there may be opportunities
or adding quality measures such as
resence of structured reporting and
ime for report generation. Further-
ore, the rates of success on initial and
ubsequent applications have not been
eported, and the reasons for which
aboratories fail to become accredited
re not well understood. Such analyses
hould be possible using data available
hrough the IAC and the ACR. Fi-
ally, assessment of the impact of ac-
reditation on patient outcomes could
rovide a powerful endorsement of the
alue of quality improvement efforts in
maging.
The participants of Imaging Quality
hink Tank II made the following
ecommendations:
1. Continue to improve accredita-
tion processes and standards.
2. Investigate the feasibility of in-
corporating additional quality vmetrics, such as structured report-
ing.
3. Initiate studies evaluating the ef-
fect of laboratory accreditation
on patient outcomes.
artnership development. Development
nd implementation of the aforemen-
ioned tools and processes will require
he coordinated efforts of a variety of
takeholders, including quality and mo-
ality experts who must define stan-
ards and subspecialty societies who
ust provide clear policy mandates that
ill drive adoption of quality principles
y their members. Laboratory accredi-
ation and personnel certifying entities
hould consider adopting these stan-
ards as requirements. Accreditation
odies should adjust their workflow
nd feedback mechanisms to ensure
ontinuous and meaningful attention to
uality as well as the development of
obust data sources to evaluate the im-
act of quality improvement processes.
he industry should recognize that tak-
ng a proactive role in driving quality will
ontribute to their products’ commercial
alue and should work to enhance this
alue through modifications in the design
nd distribution of their products. Payers
ust encourage and reward providers
ho implement quality standards and
easures as a preferred avenue to im-
roving imaging value for patients. The
atural alignments between the goals of
ractitioners, societies, imaging quality
esearchers, industry, and payers of
ealthcare services must be leveraged.
ll stakeholders should participate ac-
ively in efforts to determine the “value”
f cardiovascular imaging to hasten a
aradigm shift in how cardiovascular
iagnostic imaging is used and judged.
The participants of Imaging Quality
hink Tank II made the following
ecommendation:
1. Continue communication and
collaboration between stakehold-
ers to develop and implement im-
aging quality tools and processes.
esearch. Part of the “value” of cardio-
ascular imaging is derived from the
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238esults of clinical research in imaging.
raditionally, imaging research has fo-
used on establishing a clinical role for
n existing or emerging modality based
pon its diagnostic test performance
i.e., its sensitivity and specificity),
ather than its impact on therapy or
rognosis. These studies have typically
een small and cross-sectional with
imited follow-up time as the result of
onstraints of data collection and cost.
he current culture of accepting short-
erm studies as sufficient for the intro-
uction of new modalities fundamen-
ally undermines the feasibility of
erforming the longer-term studies
ecessary to establish the impact of
maging on meaningful outcomes.
oreover, many short-term studies do
ot adhere to the principles of design
ppropriate for diagnostic testing, in-
roducing potential bias (43).
Most importantly, however, to date
he results of many well-designed stud-
es provide limited insight into central
uestions of imaging quality. For ex-
mple, although a study in which the
uthors compare a new modality for the
ssessment of the anatomic severity of
oronary artery disease (e.g., cardiac
T angiography) with a current stan-
ard (e.g., invasive angiography) may
e adequate from a regulatory perspec-
ive to introduce this new modality into
ractice, it leaves important quality
uestions unanswered, such as optimal
atient selection, performance and in-
erpretation of the new test, as well as
he impact on outcomes including
ownstream diagnostic testing, result-
ng implementation of evidence-based
herapy, and cost (44). Thus, research
valuating new versus standard diagnostic
trategies and measuring clinical and cost
utcomes are needed in addition to those
valuating test performance.
Although research addressing the
utcomes of imaging is rare, recent
tudies can serve as examples of possi-
le strategies (45,46). For example, a
tudy by Heidenreich et al. (47) dem-
nstrated significantly greater rates of
ppropriate beta blocker use following ittachment of a clinical reminder to
chocardiogram reports of patients
ith left ventricular systolic dysfunc-
ion. Thus, novel studies focusing on
maging quality and its improvement
re beginning to emerge. In addition,
he feasibility of clinical trials of imag-
ng was discussed, with the ACR Im-
ging Network identified as an example
f a successful national trials network
42).
Several barriers have slowed progress
n developing the evidence base for
maging quality. First, the urgent need
or more informative studies is under-
ppreciated. A broad range of constit-
encies including payers, manufac-
urers, clinicians, research funding
ntities, and academics need to endorse
he importance of research that speaks
o critical questions of patient selection,
mage interpretation, reporting, and
he impact of imaging on care and
utcomes. Another obstacle is the lack
f adequate data sources. Registries, as
iscussed previously, represent an im-
ortant opportunity to provide stan-
ardized data sources comprised of ad-
quate sample sizes from diverse real-
orld practice settings, including
etailed clinical data with longitudinal
ollow-up. Research networks that use
tandardized data are another potential
esource.
Closely related to this is the likely
eed for very large sample sizes to
emonstrate that imaging might im-
rove outcomes. Assuming a trial takes
0,000 subjects to prove drug A im-
roves mortality compared to placebo,
trial of an imaging test X, which leads
o more appropriate use of drug A by
0%, would require roughly 100,000
ubjects to prove a mortality benefit
ompared to no imaging.
Limited research funding is also a
ritical impediment. In part this is at-
ributable to different standards for ap-
roving imaging equipment compared
o pharmaceuticals, which do not create
business case for extensive pre-
pproval research. Furthermore, as re-
mbursement for imaging continues to necrease, imaging providers and profes-
ional societies will have limited capac-
ty to fund implementation of quality
mprovement tools or research. As re-
earch often requires a concerted effort
mong many stakeholders, it would be
nreasonable for the imaging provider
o bear the sole responsibility for qual-
ty initiatives.
The lack of existing data, inadequate
nancial resources, limited method-
logical expertise, and poor alignment
f stakeholders are further important
arriers to investigative progress. For
xample, health plans may have data-
ases including detailed characteristics
f patients who undergo imaging and
he providers who refer for or perform
he imaging. However, they may not
ossess the methodological expertise
ecessary to take full advantage of these
ata. The exploration and development
f approaches to align existing re-
ources and to increase them is an
mportant strategy to advancing the
maging quality research agenda.
The participants of Imaging Quality
hink Tank II made the following
ecommendations:
1. Define meaningful outcome mea-
sures for clinical trials evaluating
cardiovascular imaging.
2. Promote the implementation of
data standards to facilitate large-
scale, high-impact imaging
research.
3. Continue multistakeholder in-
vestment in imaging research, in-
cluding creating an infrastructure
for a national imaging registry
and developing a network of sites
capable of performing multimo-
dality imaging.
4. Develop new and existing fund-
ing sources.
onclusions
he first ACC-Duke Imaging Quality
hink Tank meeting created a concep-
ual framework for quality in cardiovas-
ular imaging and outlined steps
eeded to improve it. The second
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239hink Tank reinforced the themes and
onclusions of the prior meeting and
utlined specific new areas of focus.
hese included structured reporting us-
ng standardized data elements across
ardiovascular imaging, ongoing work
n appropriateness criteria development
nd implementation, exploration of
maging registries, strengthening labo-SCAI/SIR 2006 appropriateness criteria for
cardiac computed tomography and cardiac
1
1
1hip development, and more robust im-
ging research, especially related to
utcomes. We hope that, in addition to
roviding forums for subspecialty soci-
ties and stakeholders for continued
iscussion of past accomplishments and
uture challenges, the legacy of these
wo Imaging Quality Think Tanks in
he broader cardiovascular imaging2008.
1
1
1
1
1
1
1
2
2
2doption of continuous quality im-
rovement for the optimal treatment of
ur patients.
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